Sage Journals: Discover world-class research

Free access

Research article

First published 2011-1

Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long-Acting versus Short-Acting Insulins?

Mark Lefkowitz

Journal of Diabetes Science and Technology

Retricted access

Case report

First published 1993-7

Treatment of Type 1 Diabetes Using a Pen-style Delivery System and a Preparation Combining Short- and Intermediate-Acting Insulin

S Okada

Journal of International Medical Research

Retricted access

Abstract

First published 2006-1

Comparison of Short-,Intermediate-,and Long-Acting Insulin Secretagogues in Type 2 Diabetes

D. Gonzalez de Serna, I. Robinson, P. Martin [...]

Journal of Investigative Medicine

Free access

Letter

First published 2011-11

Comment on “Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long Acting versus Short-Acting Insulins?”

Andreas Pfützner

Journal of Diabetes Science and Technology

Retricted access

Letter

First published 2002-12

Pharmacokinetics and Glucodynamics of Rapid-,Short-,and Intermediate-Acting Insulins: Comparison of Jet Injection to Needle Syringe

Mark J. Sarno, Jo Bell, Steven V. Edelman

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2014-12

Economic Impact of Converting from Pen and 10-mL Vial to 3-mL Vial for Insulin Delivery in a Hospital Setting

Eby Elizabeth, Lee Smolen, Amber Pitts [...]

Hospital Pharmacy

Free access

Research article

First published 2013-7

Clinical Inertia during Postoperative Management of Diabetes Mellitus: Relationship between Hyperglycemia and Insulin Therapy Intensification

Kathryn E. Coan, Andrew B. Schlinkert, Brandon R. Beck [...]

Journal of Diabetes Science and Technology

Retricted access

Research article

First published 2006-06

The Switch from Sulfonylurea to Preprandial Short- Acting Insulin Analog Substitution Has an Immediate and Comprehensive β -Cell Protective Effect in Patients with Type 2 Diabetes Mellitus

Andreas Pfützner, Babette Lorra, Michel R. Abdollahnia [...]

Diabetes Technology & Therapeutics

Retricted access

Other

First published 2004-01

Reclassifying insulins

Michael D Feher, Clifford J Bailey

The British Journal of Diabetes & Vascular Disease

Free access

Meeting report

First published 2012-7

Undeniable Need for Ultrafast-Acting Insulin: The Pediatric Perspective

Eda Cengiz

Journal of Diabetes Science and Technology

Search results